What it takes to get a new drug to market in Australia In this latest version of Thematica from TMO, we're taking a break from mines and battery science to look at the healthcare sector once again. Jonathon Davidson 1 day ago ASX News Healthcare
ADX 4DMedical partners with West Los Angeles VA Medical Center for Veteran lung imaging study Respiratory imaging technology company, 4DMedical (ASX:4DX) has entered into a research agreement with the West Los Angeles VA Medical Center for the Veteran Affairs Functional Lung Imaging Study. Keely Lynch 2 days ago ASX News Energy Healthcare Oil & Gas E&P
RCE Recce Pharma picks up Chinese patent for anti-infective drugs Recce Pharmaceuticals (ASX:RCE) has confirmed its receipt of a patent in China to protect its class of anti-infective drugs. Jonathon Davidson 2 days ago ASX News Healthcare
BB1 BlinkLab partnership with US smart-tech Turning Pointe raises hopes for autism kids BlinkLab partners with US-based Turning Pointe Autism Foundation for clinical study ahead of its FDA registration study later in the year Fouad Haidar 7 days ago ASX News Healthcare Medical Devices
LGP Little Green Pharma closely eyeing USA's legal downgrade of Cannabis danger Overnight, the Biden government did something sure to give their counterparts a stir – the USA downgraded the risk profile it gives cannabis. Jonathon Davidson 7 days ago ASX News Healthcare
OSL OncoSil's cancer device shows shrink in pancreatic tumours OncoSil's cancer device shows shrink in pancreatic tumours at a study conducted at the Royal Adelaide Hospital in South Australia Fouad Haidar 01 May 2024 11:32 (AEST) ASX News Healthcare Technology Scientific & Technical Instruments
BB1 Why Princeton Professor rates BlinkLab's autism & ADHD screening app In this interview with Sonia Madigan, Professor Sam Wang of Princeton University discusses the development and potential of BlinkLab's (ASX:BB1) AI-driven smartphone app, designed to screen for autism and ADHD. Contributor 30 Apr 2024 15:11 (AEST) ASX News Healthcare Medical Devices
OCC Orthocell's Remplir shows 85% success rate in nerve repair study Orthocell's medical device RemplirTM shows 85% success rate in latest nerve repair study, holding a promise for millions of individuals Fouad Haidar 30 Apr 2024 13:59 (AEST) ASX News Healthcare Biotechnology
RMD ResMed spikes on robust results and global growth spurt ResMed shares have climbed following the release of the company's strong Third Quarter FY2024 results. Keely Lynch 26 Apr 2024 13:45 (AEST) ASX News Healthcare Medical Devices
RCE Recce wins safety board approval to dose 4g in R327 UTI infusion trial Recce Pharma will dose patients with 4g of its R327 intravenous solution to treat UTIs in Phase I/II trials following safety board approval. Jonathon Davidson 26 Apr 2024 10:39 (AEST) ASX News Healthcare
EMD Emyria locks in $2.3M to progress MDMA research – with Chair adding $0.3M WA-based and ASX-listed Emyria is seeking to further research using MDMA to treat PTSD. The chair has funded the company $0.3M on Tuesday. Jonathon Davidson 23 Apr 2024 12:42 (AEST) ASX News Healthcare
PAA PharmAust CEO's sayanora triggers stock plunge Clinical-stage biotechnology company, PharmAust shares plunged 24 per cent so this morning, following the resignation of its CEO, Dr. Michael Thurn. Keely Lynch 23 Apr 2024 12:08 (AEST) ASX News Healthcare
GSS Genetic Signatures wins TGA greenlight for flu test device – just before winter Genetic Signatures (ASX:GSS) shares were down -1.45% to 68cps on Monday, even as the company reported a greenlight from the TGA. Jonathon Davidson 22 Apr 2024 12:02 (AEST) ASX News Healthcare Technology Scientific & Technical Instruments